Literature DB >> 16436793

Patient and physician perceptions as risk factors for oligoanalgesia: a prospective observational study of the relief of pain in the emergency department.

James Miner1, Michelle H Biros, Arleigh Trainor, Daniel Hubbard, Maryam Beltram.   

Abstract

OBJECTIVES: Previous studies have reported that pain is undertreated in the emergency department (ED), but few physician-dependent risk factors have been identified. In this study, the authors determine whether pain treatment and relief in ED patients are negatively associated with the physician's perception of whether the patient was exaggerating symptoms, and with the patient and physician's perceptions of the interaction between them, as well as whether demographic characteristics were associated with these perceptions.
METHODS: This was a prospective observational study of patients who were undergoing treatment for painful disorders in the ED. Before treatment for pain, patients were asked to complete a 100-mm visual analog scale (VAS) describing their pain. Demographic information and pain treatments administered were recorded. Patients completed a second pain VAS before discharge from the ED. Patients were then asked to complete three queries describing their perception of their interaction with the physician. After the patient had left the department, the patient's physician was asked to complete a query describing his or her perception of the interaction and to complete a VAS describing how likely it was that the patient was exaggerating symptoms to obtain pain medicines for nonmedical purposes.
RESULTS: There were 1,695 patients enrolled in the study; 32 patients were excluded because of missing or incomplete data, leaving 1,663 for analysis. Of these patients, 71.9% received a pain medication while in the ED. There was no association between the physician's VAS for perceived exaggeration of symptoms, the queries describing physician-patient interactions, and patient ethnicity and whether patients received pain treatment in the ED. There was a negative correlation between the physician's VAS for perceived exaggeration of symptoms and the change in the patient's pre- and posttreatment pain VAS scores. The physician's VAS score for perceived exaggeration of symptoms was higher among Native American patients than among other ethnic groups (p < or = 0.001). The patient and physician queries rating their interaction show a decreased absolute reduction of VAS pain scores (p > or = 0.001) and a reduction in the number of patients having at least a 50% reduction in their pain VAS score when interactions were rated "bad" and "very bad" (p < or = 0.001).
CONCLUSIONS: The physician's perception of whether a patient was exaggerating symptoms was associated with the patient's ethnic background and with both the physician's and patient's perception of their interaction. These perceptions were negatively associated with the achievement of pain relief and the change in the patient's pain VAS scores, but not with whether a patient was treated with a pain medication.

Entities:  

Mesh:

Year:  2006        PMID: 16436793     DOI: 10.1197/j.aem.2005.08.008

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  28 in total

1.  Enhancing life after cancer in diverse communities.

Authors:  Judith S Kaur; Kathryn Coe; Julia Rowland; Kathryn L Braun; Francisco A Conde; Linda Burhansstipanov; Sue Heiney; Marjorie Kagawa-Singer; Qian Lu; Catherine Witte
Journal:  Cancer       Date:  2012-03-20       Impact factor: 6.860

Review 2.  Disparities in the provision of medical care: an outcome in search of an explanation.

Authors:  Elizabeth A Klonoff
Journal:  J Behav Med       Date:  2009-01-06

3.  More educated emergency department patients are less likely to receive opioids for acute pain.

Authors:  Timothy F Platts-Mills; Katie M Hunold; Andrey V Bortsov; April C Soward; David A Peak; Jeffrey S Jones; Robert A Swor; David C Lee; Robert M Domeier; Phyllis L Hendry; Niels K Rathlev; Samuel A McLean
Journal:  Pain       Date:  2012-03-03       Impact factor: 6.961

4.  Oral oxycodone plus intravenous acetaminophen versus intravenous morphine sulfate in acute bone fracture pain control: a double-blind placebo-controlled randomized clinical trial.

Authors:  Mohammad Amin Zare; Alireza Hassan Ghalyaie; Marzieh Fathi; Davood Farsi; Saeed Abbasi; Peyman Hafezimoghadam
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-12-20

5.  Patterns of postoperative pain medication prescribing after invasive dental procedures.

Authors:  Andrei Barasch; Monika M Safford; Sandre F McNeal; Michelle Robinson; Vivian S Grant; Gregg H Gilbert
Journal:  Spec Care Dentist       Date:  2011 Mar-Apr

Review 6.  A review of the experience, epidemiology, and management of pain among American Indian, Alaska Native, and Aboriginal Canadian peoples.

Authors:  Nathalia Jimenez; Eva Garroutte; Anjana Kundu; Leo Morales; Dedra Buchwald
Journal:  J Pain       Date:  2011-02-18       Impact factor: 5.820

7.  Factors associated with refractory pain in emergency patients admitted to emergency general surgery.

Authors:  William Gilliam; Jackson F Barr; Brandon Bruns; Brandon Cave; Jordan Mitchell; Tina Nguyen; Jamie Palmer; Mark Rose; Safura Tanveer; Chris Yum; Quincy K Tran
Journal:  World J Emerg Med       Date:  2021

8.  How do physicians adopt and apply opioid prescription guidelines in the emergency department? A qualitative study.

Authors:  Austin S Kilaru; Sarah M Gadsden; Jeanmarie Perrone; Breah Paciotti; Frances K Barg; Zachary F Meisel
Journal:  Ann Emerg Med       Date:  2014-04-16       Impact factor: 5.721

9.  Improvement in physician pain perception with using pain scales.

Authors:  Umut Cakir; Yildiray Cete; Ozlem Yigit; Mehmet Nuri Bozdemir
Journal:  Eur J Trauma Emerg Surg       Date:  2017-12-01       Impact factor: 3.693

Review 10.  Physicians and implicit bias: how doctors may unwittingly perpetuate health care disparities.

Authors:  Elizabeth N Chapman; Anna Kaatz; Molly Carnes
Journal:  J Gen Intern Med       Date:  2013-04-11       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.